The effect of urologist experience on choosing active surveillance for prostate cancer

World Journal of Urology

Volumn 33, Issue 11, 2015, Pages 1701-1706

  Chu, William G ^a   Kim, Brian J ^a   Slezak, Jeff ^b   Harrison, Teresa N ^b   Gelfond, Joy ^b   Jacobsen, Steven J ^b   Chien, Gary W ^a  

^a LOS ANGELES MEDICAL CENTER   (United States)

^b Kaiser Permanente Southern California   (United States)

Author keywords

Education; Oncology; Physician patient relations; Prostate; Watchful waiting

Indexed keywords

CALIFORNIA; CANCER GRADING; CANCER STAGING; CLINICAL COMPETENCE; CLINICAL TRIAL; DISEASE COURSE; DOCTOR PATIENT RELATION; EDUCATION; ETHICS; HUMAN; MALE; MANPOWER; MEDICAL EDUCATION; MIDDLE AGED; MULTICENTER STUDY; PROCEDURES; PROSPECTIVE STUDY; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK ASSESSMENT; STANDARDS; SURGEON; UROLOGY; WATCHFUL WAITING;

CALIFORNIA; CLINICAL COMPETENCE; DISEASE PROGRESSION; EDUCATION, MEDICAL, CONTINUING; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PHYSICIAN-PATIENT RELATIONS; PROSPECTIVE STUDIES; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK ASSESSMENT; SURGEONS; UROLOGY; WATCHFUL WAITING;

EID: 84945491724     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-015-1528-1     Document Type: Article

References (14)

1. Blumenthal-Barby JS, Cantor SB, Russell HV, Naik AD, Volk RJ (2013) Decision aids: when ‘nudging’ patients to make a particular choice is more ethical than balanced, nondirective content. Health Aff 32(2):303–310. doi:10.1377/hlthaff.2012.0761
2. Carter HB, Albertsen PC, Barry MJ, Etzioni R, Freedland SJ, Greene KL, Holmberg L, Kantoff P, Konety BR, Murad MH, Penson DF, Zietman AL (2013) Early detection of prostate cancer: AUA guideline. J Urol 190(2):419–426. doi:10.1016/j.juro.2013.04.119
3. Buethe DD, Pow-Sang J (2012) Enrollment criteria controversies for active surveillance and triggers for conversion to treatment in prostate cancer. J Natl Compr Cancer Netw JNCCN 10(9):1101–1110
4. Penson DF (2012) Factors influencing patients’ acceptance and adherence to active surveillance. J Natl Cancer Inst Monogr 2012(45):207–212. doi:10.1093/jncimonographs/lgs024
5. El Hajj A, Ploussard G, de la Taille A, Allory Y, Vordos D, Hoznek A, Abbou CC, Salomon L (2013) Patient selection and pathological outcomes using currently available active surveillance criteria. BJU Int 112(4):471–477. doi:10.1111/bju.12154
6. Iremashvili V, Pelaez L, Manoharan M, Jorda M, Rosenberg DL, Soloway MS (2012) Pathologic prostate cancer characteristics in patients eligible for active surveillance: a head-to-head comparison of contemporary protocols. Eur Urol 62(3):462–468. doi:10.1016/j.eururo.2012.03.011
7. Lee MC, Dong F, Stephenson AJ, Jones JS, Magi-Galluzzi C, Klein EA (2010) The Epstein criteria predict for organ-confined but not insignificant disease and a high likelihood of cure at radical prostatectomy. Eur Urol 58(1):90–95. doi:10.1016/j.eururo.2009.10.025
8. Klotz L (2013) Active surveillance: patient selection. Curr Opin Urol 23(3):239–244. doi:10.1097/MOU.0b013e32835f8f6b
9. Fung-Kee-Fung SD, Porten SP, Meng MV, Kuettel M (2013) The role of active surveillance in the management of prostate cancer. J Natl Compr Cancer Netw JNCCN 11(2):183–187
10. Gorin MA, Soloway CT, Eldefrawy A, Soloway MS (2011) Factors that influence patient enrollment in active surveillance for low-risk prostate cancer. Urology 77(3):588–591. doi:10.1016/j.urology.2010.10.039
11. van Vugt HA, Roobol MJ, van der Poel HG, van Muilekom EH, Busstra M, Kil P, Oomens EH, Leliveld A, Bangma CH, Korfage I, Steyerberg EW (2012) Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study. BJU Int 110(2):180–187. doi:10.1111/j.1464-410X.2011.10679.x
12. Roth AJ, Rosenfeld B, Kornblith AB, Gibson C, Scher HI, Curley-Smart T, Holland JC, Breitbart W (2003) The memorial anxiety scale for prostate cancer: validation of a new scale to measure anxiety in men with with prostate cancer. Cancer 97(11):2910–2918. doi:10.1002/cncr.11386
13. Davison BJ, Oliffe JL, Pickles T, Mroz L (2009) Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer. Oncol Nurs Forum 36(1):89–96. doi:10.1188/09.ONF.89-96
14. Davison BJ, Goldenberg SL (2011) Patient acceptance of active surveillance as a treatment option for low-risk prostate cancer. BJU Int 108(11):1787–1793. doi:10.1111/j.1464-410X.2011.10200.x